The Treatment of Adult Respiratory Distress Syndrome (ARDS) Using Extracorporeal Membrane Oxygenation (ECMO) / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 1-7, 2012.
Article
em Ko
| WPRIM
| ID: wpr-145822
Biblioteca responsável:
WPRO
ABSTRACT
Extracorporeal Membrane Oxygenation (ECMO) support to tissue oxygenation has been shown to improve survival in patients with life threatening respiratory distress syndrome or cardiac failure. Extracorporeal life support such as ECMO, including extracorporeal CO2 removal (ECCO2R), is used as temporary support until successful recovery of organs. A recently published multicentre randomized controlled trial, known as the CESAR (conventional ventilation or extracorporeal membrane oxygenation for severe adult respiratory failure) trial, was the first trial to demonstrate the utility of ECMO in acute respiratory distress syndrome (ARDS). During the 2009 influenza A (H1N1) pandemic, there were many reports of patients with severe ARDS related to H1N1 infection treated with ECMO. These reports revealed a high survival rate and effectiveness of ECMO. In this review, we explain the indication of ECMO clinical application, the practical types of ECMO, and complications associated with ECMO. In addition, we explain recent new ECMO technology and management of patients during ECMO support.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Oxigênio
/
Síndrome do Desconforto Respiratório
/
Ventilação
/
Oxigenação por Membrana Extracorpórea
/
Taxa de Sobrevida
/
Influenza Humana
/
Circulação Extracorpórea
/
Pandemias
/
Insuficiência Cardíaca
/
Unidades de Terapia Intensiva
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Humans
Idioma:
Ko
Revista:
Tuberculosis and Respiratory Diseases
Ano de publicação:
2012
Tipo de documento:
Article